---
title: "NewGenIvf Group Limited (NIVF.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/NIVF.US.md"
symbol: "NIVF.US"
name: "NewGenIvf Group Limited"
industry: "Health Care Services"
datetime: "2026-05-20T11:58:02.584Z"
locales:
  - [en](https://longbridge.com/en/quote/NIVF.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/NIVF.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/NIVF.US.md)
---

# NewGenIvf Group Limited (NIVF.US)

## Company Overview

NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also offers IVF treatment; surrogacy and ancillary caring services, and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company provides its services through clinics.

| Item | Detail |
|------|--------|
| Industry | Health Care Services |
| Exchange | US Market |
| Website | [www.nivf.global](https://www.nivf.global) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: C
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-20T04:30:13.000Z

**Overall: C (0.48)**

**Industry**: Health Care Services

| Metric | Value |
|--------|-------|
| Industry Ranking | 63 / 87 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: C

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | -13.01% |  |
| Net Profit YoY | 1983.07% |  |
| P/B Ratio | 0.02 |  |
| Dividend Ratio | 0.00% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 489571.52 |  |
| Revenue | 4726433.00 |  |

#### Multi Score Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 77.23% | A |
| Profit Margin | 209.02% | A |
| Gross Margin | 20.22% | D |
| Revenue YoY | -13.01% | E |
| Net Profit YoY | 1983.07% | A |
| Total Assets YoY | 814.62% | A |
| Net Assets YoY | 1853.78% | A |
| Cash Flow Margin | -110.59% | E |
| OCF YoY | -13.01% | E |
| Turnover | 0.26 | D |
| Gearing Ratio | 20.59% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - NewGenIvf Group Limited",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "-13.01%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "1983.07%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "0.02",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "0.00%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "489571.52",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "4726433.00",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "77.23%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "209.02%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "20.22%",
          "rating": "D"
        },
        {
          "name": "Revenue YoY",
          "value": "-13.01%",
          "rating": "E"
        },
        {
          "name": "Net Profit YoY",
          "value": "1983.07%",
          "rating": "A"
        },
        {
          "name": "Total Assets YoY",
          "value": "814.62%",
          "rating": "A"
        },
        {
          "name": "Net Assets YoY",
          "value": "1853.78%",
          "rating": "A"
        },
        {
          "name": "Cash Flow Margin",
          "value": "-110.59%",
          "rating": "E"
        },
        {
          "name": "OCF YoY",
          "value": "-13.01%",
          "rating": "E"
        },
        {
          "name": "Turnover",
          "value": "0.26",
          "rating": "D"
        },
        {
          "name": "Gearing Ratio",
          "value": "20.59%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 0.05 | 1/87 | 2.20 | 0.07 | 0.05 |
| PB | 0.02 | 2/87 | 0.14 | 0.04 | 0.03 |
| PS (TTM) | 0.10 | 5/87 | 0.38 | 0.29 | 0.19 |
| Dividend Yield | 0.00% | - | - | - | - |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | Cigna (CI.US) | B | C | A | D | B | B |
| 02 | BrightSpring Health Services - Unit (BTSGU.US) | C | A | A | D | B | B |
| 03 | Fresenius (FSNUY.US) | C | B | C | C | B | B |
| 04 | Quest Diagnostics (DGX.US) | B | B | B | C | B | B |
| 05 | Labcorp (LH.US) | B | B | B | C | B | B |

## Institutional View

### Analyst Rating Distribution

> As of 2026-04-01T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 2.28 |
| Highest Target | 900.00 |
| Lowest Target | 900.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/NIVF.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/NIVF.US/norm.md)
- [Related News](https://longbridge.com/en/quote/NIVF.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/NIVF.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**